Asian Activities Report for December 7, 2011: Great Wall Motors (HKG:2333) Receives EU Whole Vehicle Type Approval for Voleex C30 and Voleex C20R

Great Wall Motors (HKG:2333) has received EU Whole Vehicle Type Approval for its Voleex C30 and Voleex C20R. Voleex C30, Great Wall's first three-box car, is one of the Top 10 Compact Family Cars in terms of sales volume in China in 2011, and has already been sold to more than 50 countries and regions. Voleex C20R, a cross vehicle type featuring sports characteristics and multiple functions, provides superior comfort and driving excitement.

Chevalier International Holdings Limited (HKG:0025) has entered into a letter of intent in relation to possible acquisitions of certain hot spring hotels in Japan. Chevalier International is principally engaged in construction and engineering, insurance and investment, property development and investment, food and beverages, and computer and information communication technology. The acquisition, if completed, will help Chevalier diversify its income stream and gain from the development of the Japanese tourism industry.

Daiichi Sankyo Co., Ltd (TYO:4568) advises that its subsidiary Ranbaxy Laboratories Ltd. (BOM:500359), India's largest pharmaceutical company, has received final approval from the U.S. Food and Drug Administration to manufacture and market Atorvastatin, a cholesterol-reducing medicine, in the US market. Atorvastatin will provide a safe, effective, affordable and accessible alternative to Pfizer's (NYSE:PFE) cholesterol-lowering medication Lipitor, which generated total annual sales of US$7.89 billion in the US through September 2011.


Related Companies

Ranbaxy Laboratories Limited
      

Pfizer Inc.
         

Great Wall Motor
     

Daiichi Sankyo Company, Limited
     

Chevalier International Holdings Limited